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Wide-neck intracranial aneurysms were originally thought to be either untreatable or very
challenging to treat by endovascular means because of the risk of coil protrusion into
the parent vessel. The introduction of the balloon remodeling technique (BRT) and later
stents specifically designed for intracranial use has progressively allowed these lesions
to be endovascularly treated. BRT and stent-assisted coiling technique (SACT) were first
designed to treat sidewall aneurysms but, with gained experience and further technical
refinement, bifurcation complex-shaped wide-neck aneurysms have been treated by coil-
ing enhanced by BRT and SACT. In this article, we will review and describe the inherent
benefits and drawbacks of BRT as well as SACT.
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INTRODUCTION
Wide-neck (when the neck is ≥4 mm, or when the dome/neck
ratio <1.5–2) intracranial aneurysms were originally thought to
be either untreatable or very challenging to treat by endovascular
means because of the risk of coil protrusion into the parent ves-
sel. The introduction of the balloon remodeling technique (BRT)
and later stents specifically designed for intracranial use has pro-
gressively allowed these lesions to be endovascularly treated. BRT
and stent-assisted coiling technique (SACT) were first designed
to treat sidewall aneurysms but, with gained experience and fur-
ther technical refinement, bifurcation complex-shaped wide-neck
aneurysms have been treated by coiling enhanced by BRT and
SACT. In this article, we will review and describe the inherent
benefits and drawbacks of BRT as well as SACT. The specific role
of flow diverter stents in the endovascular treatment of cerebral
aneurysms will not be addressed in this article.
BALLOON REMODELING TECHNIQUE
VARIOUS TECHNIQUES OF BALLOON REMODELING
The standard coil embolization (stand-alone coiling) technique
is limited by its inability to occlude wide-neck aneurysms. The
BRT consists in the temporary inflation of a non-detachable bal-
loon across the aneurysm neck during each coil placement to
avoid inadvertent coil protrusion into the parent artery as ini-
tially described by Moret et al. nearly two decades ago (1). At the
end of the procedure, the balloon is removed and no device is
left in place in the parent vessel (unless stent placement is subse-
quently performed). Some balloon catheters allow the placement
of a stent at the end of the procedure by inserting the stent into the
lumen of the balloon microcatheter after withdrawal of the wire
(2). The “classic” BRT, using a single low-compliance balloon, was
initially limited to sidewall aneurysms, and was often inadequate
for protection of both the neck and arterial branches of complex
bifurcation aneurysms. Nowadays, the most popular remodeling
balloon microcatheters are the HyperGlide™ (compatible with
0.010′′ microguidewire), the Transform™, and the Septer™ (both
compatible with 0.014′′ microguidewires). Balloons compatible
with 0.014′′ microwire seem more stable than balloon operating
on 0.010′′ platforms but induce more deformation of the cere-
bral arteries during navigation. The Septer™ has two independent
lumens, giving to the operator the opportunity to navigate coils
or some microstents while the balloon is still inflated. For bifur-
cated lesions, the use of more compliant balloon (compliance is a
mechanical property defined by the propensity of the balloon to
change its cylindrical shape to the anatomy of the vessel in which
it is inflated) allows the treatment of complex, wide-neck bifur-
cation aneurysms for which the standard embolization technique
would not have permitted safe (regarding the patency of bifurca-
tion arterial branches) endovascular occlusion. In these situations,
it is necessary to completely protect the neck to avoid coil protru-
sion. Several options are available. First, a more compliant balloon
can be used to mold the neck and the origin of bifurcation branches
(3). The most popular compliant balloons microcatheters are the
HyperForm™ (compatible with 0′′ microguidewire), the Trans-
form™ C and SC (C and SC for compliant and super compliant,
respectively) and the Septer C and SC™ (both compatible with
0.014 microguidewires). An alternative to the use of a super com-
pliant balloon consists in the placement of two balloons instead of
one (one balloon in each of the bifurcated arterial branches) (4).
The third option consists in the navigation of the balloon through
the circle of Willis to cross and protect the aneurysm neck (e.g.,
to navigate from the internal carotid, the posterior communicat-
ing arteries and the P1 segment of both posterior cerebral arteries
to protect the neck of a basilar tip aneurysm) (5). Another tech-
nique consists in the navigation of a dual-lumen balloon in front
of the neck to allow coil deposition through the second lumen of
the balloon microcatheter (6). Nowadays, BRT can be used in all
aneurysm locations.
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COMPLICATIONS AND CLINICAL OUTCOME OF BRT
The two most frequent and feared complications of the endovas-
cular treatment of intracranial aneurysms are thromboembolic
events and aneurysm perforation. The use of an adjunctive balloon
for aneurysm coiling has raised some concerns about potential
added morbidity over the standard coiling procedure. In a recent
large prospective multicenter study, a consecutive series of patients
with ruptured aneurysms (the CLARITY study) who underwent
endovascular treatment with either conventional coil embolization
or BRT showed that both techniques had similar safety in terms of
perioperative complications and clinical outcome (7). The overall
rate of treatment-related complications, with or without clinical
manifestations, was 17.4% with coil embolization and 16.9% with
BRT. The difference in the rates of thromboembolic events, intra-
operative rupture, and early rebleeding between the two treatment
groups was not statistically significant. The cumulative morbid-
ity and mortality rate related to the treatment in the remodeling
group (3.8%) was similar to that in the stand-alone coil emboliza-
tion group (5.1%). Likewise, the global cumulative morbidity and
mortality rates related to both the treatment and the initial hemor-
rhage did not differ significantly between groups (16.2% with BRT
and 19.6% with coil embolization). In the ATENA study (unrup-
tured aneurysms) (8), the overall complication rate, regardless of
whether the adverse events led to clinical consequences, was 10.8%
for standard coiling of unruptured aneurysms and 11.7% for BRT
of unruptured aneurysms. The morbidity and mortality rates did
not differ significantly between groups: 3.1% in the standard treat-
ment group and 3.7% in the BRT group, respectively (8). In the
Shapiro et al. review article (9), in ruptured aneurysms, the clinical
outcome was a symptomatic event or death in 2.7% in the stand-
alone coiling group and 1.7% in the BRT group. In unruptured
aneurysms, clinical outcome was a symptomatic event or death in
0.6% in the stand-alone coiling group and 0.9% in the BRT group.
Table 1 provides with an overview of the rates of complications
with BAT.
ANEURYSM PERFORATION
In the Shapiro et al. review article (9), the rate of intraop-
erative rupture was 3.4% in ruptured aneurysms treated with
standard coiling, 1.7% in ruptured aneurysms treated with the
remodeling technique, 1.4% in unruptured aneurysms treated
with standard coiling, and 1.8% in unruptured aneurysms treated
with the remodeling technique. In the ATENA study (unruptured
aneurysms) (8), the rate of intraoperative rupture was 3.2% in the
Table 1 | Balloon remodeling technique and complications with
clinical significance.
Morbi-mortality
Stand-alone
coiling (%)
BRT
(%)
CLARITY, ruptured aneurysms (7) 5.1 3.8
ATENA, unruptured aneurysms (8) 3.1 3.7
Shapiro et al. review, ruptured aneurysms (9) 2.7 1.7
Shapiro et al. review, unruptured aneurysms (9) 0.6 0.9
remodeling group and 2.2% in the coiling group. In the Sluzewski
et al. personal series (10), the rate of intraoperative rupture was
higher in the remodeling (4.0%) compared with the coiling group
(0.8%). In the CLARITY study (ruptured aneurysms), the rates of
intraoperative rupture were similar in both BRT and stand-alone
coiling groups (7).
THROMBOEMBOLIC COMPLICATIONS
In the Shapiro et al. review (9), the rate of thromboembolic events
was similar in patients treated with coiling (8.1%) and remodeling
(8.0%). Symptomatic thromboembolic events were encountered
in 4.6% of patients treated with coiling and 4.4% of patients
treated with remodeling. Death related to thromboembolic events
was reported as 1.2% for patients treated with coiling and 0.4%
for patients treated with remodeling. In the Layton et al. series
(11), the rate of thrombus formation was not significantly dif-
ferent in patients treated with standard coiling compared with
the remodeling technique (9 and 14%, respectively). Symptomatic
thromboembolic events were also observed in a similar percentage
of cases (5% in standard coiling and 7% in remodeling). Similarly,
Brooks et al. reported that diffusion-weighted-imaging abnormal-
ities were detected in 32% in the coiling group and 24% in the BRT
(12). Conversely, Sluzewski et al. reported that the rate of throm-
boembolic events was higher in the remodeling group (9.8%)
compared with the coiling group (2.2%) (10). In the ATENA
study, thromboembolic events occurred in 6.2% in the stand-alone
coiling group versus 5.4% in the BRT group (8).
ROLE OF BALLOON INFLATION TIME FOR BRT REGARDING ISCHEMIC
COMPLICATIONS
Critical questions regarding the maximum permissible balloon
occlusion time, the minimum effective reperfusion time between
inflations, and whether total balloon inflation time or the number
of inflations is a higher risk factor of BRT than stand-alone coiling
for ischemic complications has been assessed using diffusion-
weighted MR imaging (13, 14). For Albayram et al., the only
variables found to influence this risk during or after BRT coil
placement were microcatheter repositioning, coil removal and
repositioning, and size of the aneurysmal neck (13). More recently,
Spiotta et al. found that asymptomatic ischemic event rate in this
population for BRT embolization was 24.7%, a rate equal to stand-
alone coiling of patients treated in the same time period without
BRT (14). Both silent and symptomatic ischemic rates were sim-
ilar in the internal control group. It is possible that the higher
rate of antiplatelet therapy in the BRT group is masking a higher
ischemic rate. The baseline patient risk factors for ischemic com-
plications identified included older age and diabetes. One possible
explanation for this finding is that all patients have intraproce-
dural showering of emboli, but older and diabetic patients are
more likely to have irreversible ischemia attributable to preexisting
microvascular disease. Embolic infarcts were more common than
watershed infarcts. The total number of inflations times, the max-
imum occlusion time, minimum reperfusion time between two
consecutive inflations, and mean reperfusion time did not appear
to be risk factors for thromboemboli. However, higher maximum
inflation time was significantly correlated to watershed pattern
infarcts.
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ANATOMIC RESULTS OF THE BRT
The Shapiro et al. literature review does not confirm the Sluzewski
et al. findings (9, 10). Both initial and follow-up aneurysm occlu-
sion rates were higher in BRT cases. The initial total occlusion rate
was 73% in patients in the BRT group and 49% of patients in
the standard coiling group, subtotal occlusion in 22% in the BRT
group and 39% in the coiling group, and incomplete occlusion in
5% in the BRT group and 13% in the coiling group. At follow-up,
there were similar results: total occlusion in 72% of patients in
the BRT group and 54% of patients in the standard coiling group,
subtotal occlusion in 17% in the BRT group and 34% in the coil-
ing group, and incomplete occlusion in 10% of the BRT group and
11% of the coiling group. According to the ATENA and CLARITY
studies, results are possibly different in unruptured and rup-
tured aneurysms. In ATENA (unruptured aneurysms), immediate
anatomic results reported were similar in both stand-alone coiling
and BRT groups (complete occlusion in 59.8% of aneurysms in
the stand-alone coiling group and 59.8% of aneurysms in the BRT
group) (8). In CLARITY (ruptured aneurysms) (7), immediate
anatomic results were different, the rate of adequate angiographic
aneurysm occlusion being significantly higher in the BRT group
(94.9%) than in the stand-alone coil embolization group (88.7%).
A recent meta-analysis from Shapiro et al. demonstrated that
although balloon use was associated with superior initial and
follow-up angiographic occlusion rates (9).
STENT-ASSISTED COILING OF INTRACRANIAL ANEURYSMS
RATIONALE FOR THE STENTING OF INTRACRANIAL ANEURYSMS
The widespread acceptance of coiling has been hindered by the
potential for aneurysm to recur over time after coiling (15).
This issue is even more relevant for large aneurysms for which
angiographic recurrence is more likely than smaller lesions (16).
However, fusiform and some wide-neck aneurysms remained
unaddressed by both reconstructive surgical and endovascular
techniques until the introduction of dedicated intracranial self-
expandable stent. Stent deployment across the aneurysm neck,
followed by coil packing of the aneurysm, has progressively
been more widely adopted, particularly for wide-neck complex
aneurysms, in order to stabilize the coil mass inside the aneurys-
mal sac and to avoid coil herniation into the parent artery (17,
18). Some authors have also advocated using the stent (or several
stents deposited in a telescopic fashion to augment mesh density)
as a stand-alone procedure to treat fusiform aneurysms, obtain-
ing progressive aneurysm thrombosis without the adjunct of coils
within the aneurysm sac (19–23). With gained experience, SACT
has been employed to treat a larger range of aneurysms (not only
wide-neck and complex aneurysms) with the idea of the likeli-
hood of diminished risk of aneurysm recurrence (24–26). The
major current concern is the small size of the parent vessel rela-
tive to the diameter of the smallest available stent with inherent
potential suboptimal stent deployment. Nevertheless, some stents
can be adequately deployed even in vessel smaller than 2 mm (27).
Conversely, the use of SACT has brought with it other important
considerations, including the necessity of antiplatelet therapy that
carries inherent risks of intracranial bleeding (28, 29). Moreover,
antiplatelet therapy is limited in the setting of subarachnoid hem-
orrhage for the majority of the operators (30). The other drawback,
even if limited, of SACT is the potential for delayed stent-related
issues such as the development of in-stent stenosis and parent
vessel occlusion (31–33).
CLOSE- AND OPEN-CELL DESIGNS FOR SELF-EXPANDABLE STENT
There are two major different, close- and open-cell designs for the
construction of self-expanding stents dedicated to the intracranial
use. The close-cell design makes the stent to work as a whole body
(e.g., Enterprise™); thus, a force used at one end will be trans-
mitted to the other end immediately. For a stent with open-cell
design (e.g., Neuroform™), each independent segment can serve
as a separate fixing device, to enhance apposition of the stent to the
arterial wall, and a force used at one end will not be transmitted
to the other end so easily. Open-cell design stents better cover the
aneurysm neck when compared to close-cell stents, and induce
less straightening of the vessel. The open-cell stents have, however,
less struts apposing well to the vessel wall compared to close-cell
stents (34). Open-cell stents conforms better to vascular tortu-
osities. However, open-cell stents may show increased opening of
cells and outward prolapse of struts into an aneurysm neck when
situated at the convexity of the curvature, whereas at the concavity,
struts, or stent segments may protrude inward.
When a closed-cell stent is bent, it has less flexibility to con-
form to a curved or irregular anatomy. The close-cell unsegmented
design does not allow the stent to lengthen at the outer curve or
to shorten at the inner curve. This limitation in adapting to a
vessel curvature will cause flattening of the stent or kinking (35)
resulting in incomplete stent apposition. Incomplete stent apposi-
tion has recently been found to be a critical factor associated with
higher thromboembolic complication rates in SACT embolization
of intracranial aneurysms (36). The major advantage of a close-
cell stent is ability to be deployed in the vessel lumen and resheated
in its delivery microcatheter, allowing the operator to optimize the
position of the stent regarding the aneurysm neck. Conversely, an
open-cell stent, once partially delivered, cannot be resheated and
repositioned owing to its design consisting in independent stent
segments soldered by connectors.
There are two different types of close-cell stents: laser-cut (as
the Enterprise™) or woven (as the LVIS™ and the LEO™). Nowa-
days, the last two stents offer the lowest profile to be delivered in a
0.017′′ inner lumen microcatheter.
STENTING TECHNIQUES
Four options may be proposed. Firstly, the coil delivery micro-
catheter can be placed first within the aneurysm lumen to allow
coil delivery and then the stent is positioned and immediately
delivered across the aneurysm neck (jailed-catheter technique).
Secondly, the stent can be first delivered across the aneurysm neck
and then the coiling microcatheter is placed within the sac through
the stent struts (trans-cell technique) (Figure 1) (37). Finally, the
aneurysm can be coiled with or without the balloon remodeling
technique and then the stent is delivered across the aneurysm neck
at the end of the procedure, aiming at decreasing the recanaliza-
tion rate by diminishing intra-aneurismal flow by diversion and
also by creating a mesh at the level of the neck to be colonized and
covered by endothelial cells (25). On the other hand, delivering
the stent prior to aneurysm coiling has some drawbacks. Firstly,
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FIGURE 1 | Jailed-catheter and trans-cell techniques.
the jailed-catheter technique does not offer the possibility to mod-
ify the microcatheter position within the aneurysm sac, resulting
in many instances in the diminution of aneurysm packing with
coils. Secondly, when the stent is deployed prior to the coil deliv-
ery microcatheter placement, the operator should be very cautious
while catheterizing the aneurysm through the stent strut in keep-
ing with the potential hazard of stent displacement and stent cell
impingement (38). A fourth SACT, the stent-jack technique, has
been more recently described. It consists in positioning the coil
delivery microcatheter first into the aneurysm sac, then navigating
a self-expandable stent into the parent vessel without delivering
the stent before the first coil is deposited in the sac (39). The first
coil is placed into the sac (no matter if a coil loop was slightly
protruding into the arterial lumen) with coil deployment aim-
ing at forming the most homogenous framing of the aneurysm
sac. As a next step, before coil detachment, the stent is carefully
deployed across the neck. Once the stent is delivered, the first coil
is detached. If necessary, additional coils are introduced into the
aneurysm to obtain circulatory exclusion of the lesion.
STENTING OF BIFURCATION ANEURYSMS
Stents have been designed originally to treat sidewall aneurysms.
Single-stent SACT is suitable for many bifurcation aneurysms, as a
stand-alone technique or in conjunction with BRT (the balloon to
be placed in one of the bifurcated branch, the stent being delivered
in the other branch). More recently,double stenting in aY or X con-
figuration may be used to treat a subset of wide-necked aneurysms
not amenable to reconstruction with a single-stent due to anatom-
ical conformation (40, 41). Y- and X-stent reconstructions enable
the endovascular management of otherwise complex, wide-neck
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cerebral aneurysms and can be performed as safely as single-stent
technique in experienced hands with satisfactory results.
Y-stent and waffle-cone technique
The Y-stent technique has been developed first to treat wide-neck
basilar tip aneurysms (42). It includes the crossing-Y and kissing-
Y techniques (43). The crossing Y-stent technique is based on the
strategy that a second stent is advanced through the first stent
interstices and into the contralateral branch vessel. By contrast
the kissing technique, two stents are deployed in a parallel fashion
from both daughter arterial branches down to the main arterial
trunk, forming a kissing-Y configuration. The first bifurcation ves-
sel to be stented is determined according to the angle between the
proximal parent vessel and the arterial branches just distal to the
aneurysm; the branch with a sharper angle to be stented before
the one with wider angle. In 2004, Horowitz et al. described a
single-stent technique to treat broad-neck bifurcation aneurysm
consisting in a single-stent to be placed partially into the aneurysm
and into the afferent artery, the portion of the stent protruding into
the aneurysm fundus providing neck support for the subsequent
successful coiling (44).
X-stent technique
Anterior communicating artery (AcoA) aneurysms may present
with complex anatomic features, often associated with a wide-neck
and variety of anomalies. X-configured stent-assisted coiling for
treatment of wide-neck and complex AcoA aneurysms, for which
otherwise there would be no endovascular treatment alternative
(40, 45). Of course, X-stent placement is to be reserved for patients
having good-sized A1 segments, bilaterally. The side of the first
stent is determined according to the angle between the A1–AcoA
complex and the contralateral A2; the A2 with a sharper angle to
be stented before the one with wider angle. On the basis of this
decision, the first stent is placed across the aneurysm neck, extend-
ing from the contralateral A2 to the ipsilateral A1 segment, crossing
through the AcoA. Then after, the second stent is crossed from the
other side. Both strut crossing and kissing stenting technique have
been reported (40, 45–47).
EFFECT OF SACT ON IMMEDIATE ANGIOGRAPHIC OUTCOME AND AT
FOLLOW-UP
Immediate angiographic complete occlusions are obtained less
frequently in stented than in the not stented aneurysms. This
is because larger aneurysms are more likely to be stented than
small aneurysms, and that dual antiplatelet therapy impacts on
the immediate intra-aneurysmal thrombosis. Moreover, the use
of dual antiplatelet therapy during the procedure in addition to
heparin does not favor immediate per procedural sac thrombo-
sis (25). Tight coiling is more difficult to obtain when the stent
is implanted prior to coiling, giving less maneuverability to the
coiling microcatheter thus resulting in looser aneurysm packing.
Conversely, at follow-up, complete occlusions increased to
73.4% in the stent-assisted group, while it diminished to 54.0%
in the no-stent group. For stent-assisted coiling, numerous arti-
cles have reported a broad range (13.2–94.4%) of immediate
complete occlusion (48–54). However, most mid-to-long-term
follow-up series have reported augmented rates of angiographic
complete occlusion at follow-up (range 54–81%) (24–26, 49–62).
An absence of stent has been identified as one of the most rele-
vant factors for angiographic recurrence (25). This durability can
be explained by the combination of biological, geometrical, and
hemodynamic mechanisms (63–68). Hemodynamic effects of the
stents in the endovascular treatment of aneurysms include dis-
ruption of intra-aneurysmal flow pattern, resulting in turbulence,
and production of blood stasis within the aneurysm, resulting
in aneurysmal thrombosis. This hemodynamic effect seems even
more preeminent in case of Y-stenting (65).
COMPLICATIONS OF SACT
There are more procedure-related complications than in the stand-
alone coiling. The main cause of morbidity and mortality is
thromboembolism. The necessity of dual antiplatelet therapy in
SACT is also known to increase the risk of hemorrhagic complica-
tions (69). Thromboembolic complications are also more frequent
in the stented patients (70). Antiplatelet activity assessment prior
to stent delivery allows diminishing the occurrence of such com-
plications by identifying the patients not responding to antiplatelet
drugs (71, 72). In a recent review article, Shapiro et al. reported
an overall complication incidence of 19%, with an overall death
incidence of 2.1%. Thromboembolic issues were most prevalent
at close to 10%, leading to death in 0.6% of overall cases. Hem-
orrhagic complications occurred in 2.2% of cases but carried a
higher association with mortality, accounting for 0.9% of over-
all deaths. Coil-related technical issues were infrequent (2%) and
almost always asymptomatic. Complication rates decrease over-
time while the operator practice of stenting increased showing
also the effect of a learning curve (26). More recently, Nishido
et al. have reported 7.0% of ischemic and 2.3% of hemorrhagic
complications with an overall rate of procedure-induced mortality
of 2.7% with SACT (73). Geyik et al., in a series of 500 consecutive
SACT aneurysms, reported 5.6% of thromboembolic and 0.8%
of hemorrhagic complications, with a procedure-related mortal-
ity of 0.8% (74). Table 2 provides with an overview of the rates of
complications with SACT.
SACT IN THE ACUTE SETTING OF SAH
The use of SACT in the acute setting of subarachnoid hemorrhage
remains controversial despite positive results reported in limited
series (75, 76). It appears that the risks of intracranial hemor-
rhage are augmented in this particular condition. In their review
article, Bodily et al. reported that SACT in ruptured aneurysms
Table 2 | Stent-assisted coiling technique complications with clinical
significance.
Morbi-mortality
Stand-alone
coiling and BRT
SACT
Nishido et al. (73) unruptured and
ruptured aneurysms
5.6% 9.4%
Shapiro et al. (10) review, unruptured
and ruptured aneurysms
NA 12.2%
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could be performed with high degrees of technical success, but
adverse events appeared more common and clinical outcomes
were likely worse than those achieved without stent assistance (30).
The optimal antiplatelet medication during acute-phase treatment
has yet to be determined, and a longer follow-up series is needed
to evaluate the long-term efficacy and safety of stent-assisted coil
embolization during acute SAH. In a series of 36 patients, Golshani
et al. found that SACT was an option for treatment of ruptured
wide-neck ruptured aneurysms and for salvage treatment during
unassisted embolization of ruptured aneurysms but complication
rates appeared to be higher than for routine clipping or coiling of
cerebral aneurysms (28). This applies even more dramatically to
the patients requiring ventriculostomy (77).
WHEN TO USE BAT
In our center, BAT is used in slightly over 60% of the cases for
both ruptured and unruptured aneurysms. BAT provides the abil-
ity to avoid coil protrusion and to protect from the deleterious
effect of a massive subarachnoid hemorrhage in case of aneurysm
perforation. The balloon can be immediately inflated in case of
dome (re)rupture during intervention. The main drawback of
the technique is the need for dual femoral approach, augment-
ing the potential for access site complications. Alternatively some
operators advocate the use of a single guiding catheter (with a min-
imal inner lumen diameter of 0.070′′), allowing the navigation of
both the balloon and the coil delivery microcatheters. The main
drawback of this single guiding catheter technique is the potential
inadvertent forward and backward movements of one of the two
microcatheters while manipulating the second one.
WHEN TO USE SACT
The need for dual antiplatelet therapy makes the SACT to be
avoided in acutely ruptured aneurysms. In this setting, SACT
should be reserved as a bail-out procedure to avoid parent ves-
sel closure when inadvertent coil protrusion is threatening. We
rather prefer to perform a partial coiling to protect the fundus of
the aneurysm to avoid early rebleed and to carry back the patient to
the angiographic suite a few weeks later to optimize the aneurysm
occlusion with the adjunct of a stent if required.
ANTIPLATELET THERAPY MANAGEMENT FOR ELECTIVE SACT
Our standard dual antiplatelet regimen is based on the oral admin-
istration of clopidogrel and aspirin. Instead of using a loading dose
of clopidogrel we initiate dual antiplatelet therapy (clopidogrel and
oral aspirin) 10–15 days prior to the procedure. For antiplatelet
activity assessment we use the VerifyNow (Accumetrics, San Diego,
FIGURE 2 | Flow chart of our antiplatelet therapy assessment prior to
elective stent-assisted coiling procedures. The patient is given
clopidogrel and aspirin (250 mg daily) at Day 1. Because clopidogrel is a
prodrug treatment should be initiated 5–6 days before efficacy
assessment. PRU, platelet reaction unit; SACT, stent-assisted coiling
technique.
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CA, USA) system which a bedside system that is requiring mini-
mal manipulation. This measurement is based on the principles
of optical aggregometry. Because low responder patients may not
be recognized with loading dose we rather prefer to initiate the
treatment with a standard dose of Clopidogrel (75–150 mg daily).
Our protocol has been standardized and applied to all patients
for whom elective aneurysm treatment with SACT is scheduled
(Figure 2).
CONCLUSION
Despite the fact that aneurysms treated by the remodeling tech-
nique are different from aneurysms treated with standard coiling,
the safety of both techniques is similar with a higher anatomic
efficacy of the remodeling technique. Accordingly, wide use of
the remodeling technique can be proposed. SACT is associated
with a higher mortality compared with coiling with or without
remodeling and remains more hazardous than stand-alone or BRT
coiling in keeping with augmented risks of both ischemic and
hemorrhagic insults. However, SACT reduce significantly angio-
graphic recurrence, a factor that alters the results of endovascular
treatment over surgical clipping. In the setting of subarachnoid
hemorrhage, SACT should be reserved to the otherwise untreat-
able aneurysm, even if BRT is used, in order to protect the patient
from early rebleeding. The optimal antiplatelet regimen in the
acute setting has not been determined yet.
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